• A genome-wide "pleiotropy scan" does not identify new susceptibility Loci for estrogen receptor negative breast cancer 

      Campa, D; Barrdahl, M; Tsilidis, KK; Severi, G; Diver, WR; Siddiq, A; Chanock, S; Hoover, RN; Ziegler, RG; Berg, CD; Buys, SS; Haiman, CA; Henderson, BE; Schumacher, FR; Le Marchand, L; Flesch-Janys, D; Lindstrom, S; Hunter, DJ; Hankinson, SE; Willett, WC; Kraft, P; Cox, DG; Khaw, KT; Tjønneland, A; Dossus, L; Trichopoulos, D; Panico, S; Van Gils, CH; Weiderpass, Elisabete; Barricarte, A; Sund, M; Gaudet, MM; Giles, G; Southey, M; Baglietto, L; Chang-Claude, J; Kaaks, R; Canzian, F (Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
    • The INSIG2 rs7566605 polymorphism is not associated with body mass index and breast cancer risk 

      Campa, D; Lund, Eiliv; Husing, A; McKay, JD; Sinilnikova, OM; Vogel, U; Tjonneland, A; Overvad, K; Stegger, J; Clavel-Chapelon, F; Chabbert-Buffet, N; Fagherazzi, G; Trichopoulou, A; Zylis, D; Oustoglou, E; Rohrmann, S; Teucher, B; Fisher, E; Boeing, H; Masala, G; Krogh, V; Sacerdote, C; Panico, S; Tumino, R; Onland-Moret, NC; van Gils, CH; Bueno-de-Mesquita, H. Bas; Chirlaque, MD; Sala, Núria; Quiros, JR; Ardanaz, E; Amiano, P; Molina-Montes, E; Hallmans, G; Lenner, P; Travis, R; Key, TJ; Wareham, N; Khaw, KT; Rinaldi, S; Slimani, N; Chajes, V; Siddiq, A; Riboli, E; Kaaks, R; Canzian, F (Journal article; Tidsskriftartikkel; Peer reviewed, 2010)